TRV-2026-3065Version 1 · Published

Saved · see the current record

Why this version exists

Certified into the record

The exact text we saved

This is the version exactly as it was saved, character for character. The SHA-256 hash below is a 64-character code worked out from that text. Run the same text through SHA-256 and you get the same code; change a single letter and the code comes out completely different. Each version also stores the previous version’s hash, which chains them together so no version can be swapped out quietly.

TRUVACE RECORD VERSION
record: TRV-2026-3065
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-11-20T00:02:16.242602Z
status: published
lens: g_space
sector: health
headline: Multicenter evaluation of radiomics and multimodal artificial intelligence for colorectal cancer diagnosis and survival prediction
dek: Abstract Reliable preoperative classification and outcome prediction could improve management of locally advanced colorectal cancer. We retrospectively studied 879 participants from two centers, including 741 patients with locally advanced colorectal cancer and 138 with benign colorectal lesions. Clinical, radiomics, deep learning, and early fusion models were trained at center A ( n = 615) and independently tested at center B ( n = 264) using pretreatment contrast-enhanced computed tomography and clinical data.…
gain_title: In a retrospective study of 879 patients at two centres, a clinical-radiomics model trained at one centre separated malignant from benign colorectal lesions with a test AUC of 0.957 at the second centre.
problem_title: (none)
trace_subject: (none)
gain_reading: In a retrospective study of 879 patients at two centres, a clinical-radiomics model trained at one centre separated malignant from benign colorectal lesions with a test AUC of 0.957 at the second centre.
gain_evidence: The clinical-radiomics nomogram achieved a test AUC of 0.957 for benign-malignant classification. | radiomics achieved test AUCs of 0.874 and 0.898
problem_reading: (none)
problem_evidence: (none)
quick_read: Researchers retrospectively analysed 879 participants from two centres, 741 with locally advanced colorectal cancer and 138 with benign colorectal lesions. Models were trained on pretreatment contrast-enhanced CT scans and clinical data. A clinical-radiomics nomogram reached a test AUC of 0.957 for telling benign from malignant lesions.

For overall survival, radiomics reached test AUCs of 0.874 at three years and 0.898 at five years. A deep learning fusion model scored 0.870 and 0.899, essentially matching it.

The authors conclude that CT radiomics is a promising digital biomarker for stratifying colorectal cancer, while early deep learning fusion adds limited value over an optimised radiomics baseline.
limitation: The study was retrospective, and the early deep learning fusion approach offered limited incremental value over an optimized radiomics baseline.
tag: Evidence-backed gain
key_points: The study included 879 participants from two centres: 741 with locally advanced colorectal cancer and 138 with benign lesions. | Clinical, radiomics, deep learning and early fusion models were trained at center A (n = 615). | Models were independently tested at center B (n = 264). | Inputs were pretreatment contrast-enhanced CT and clinical data. | The clinical-radiomics nomogram reached a test AUC of 0.957 for benign-malignant classification. | Three-year survival test AUC was 0.874 for radiomics and 0.870 for fusion; five-year was 0.898 and 0.899.
rundown: The study was retrospective and covered two centres. Center A supplied 615 participants for training, and center B supplied 264 for independent testing, which gives the results an external check.

The models compared were clinical, radiomics, deep learning and early fusion, all built on pretreatment contrast-enhanced CT and clinical data. The aim was better preoperative classification and outcome prediction in locally advanced colorectal cancer.

The clinical-radiomics nomogram scored a test AUC of 0.957 for benign versus malignant. Survival predictions were similar across approaches: radiomics 0.874 and 0.898, fusion 0.870 and 0.899 at three and five years.
sources:
- peer_reviewed | npj Digital Medicine | https://doi.org/10.1038/s41746-026-03434-3 | 2026-11-19
prev: 0000000000000000000000000000000000000000000000000000000000000000
SHA-256 hash
7daa54e0f80ff745eef1ff7162e01ebce4e31fc5f004b6609a0faf23992b0a0c
Previous version’s hash
0000000000000000000000000000000000000000000000000000000000000000
Check this record hasn’t been altered
How to check it yourself, without trusting this page

Download any version from /api/record/TRV-2026-3065 and hash its canonical field yourself, for example with shasum -a 256. You should get its content_hash. Each version’s text also ends with prev:and the hash of the version before it (version 1 points to 64 zeros). If anyone had changed a single character of any version after it was saved, those hashes wouldn’t line up.